Inhibitory action of peripheral-type benzodiazepines on dopamine release from PC12 pheochromocytoma cells

M. Ohara-Imaizumi, K. Nakazawa, T. Obama, K. Fujimori, A. Takanaka, K. Inoue

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Characteristics of the benzodiazepine inhibition of dopamine (DA) release in PC12 cells were investigated. Diazepam inhibited DA release evoked by high concentrations of extracellular. K+ in a dose-dependent manner (IC50, 10 μM). Ro 5-4864 [7-chloro-1,3-dihydro-1-methyl-5-(p-chlorophenyl)-2H-1,4- benzodiazepine-2-one], a peripheral-type benzodiazepine, also inhibited DA release effectively. PK 11195 [1-(2-chlorophenyl)-N-methyl-N-(1- methylpropyl)-3-isoquinoline carboxamide], a benzodiazepine generally considered a peripheral-type benzodiazepine receptor antagonist, did not antagonize the inhibition induced by diazepam, but rather inhibited DA release itself. On the other hand, the central-type benzodiazepines, clonazepam and Ro 15-1788 {ethyl-8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H- imidazo[1,5a][1,4]benzodiazepine-3-carboxylate} did not affect the DA release. Diazepam, Ro 5-4864 and PK 11195 also inhibited a Ba++-current carried by voltage-gated Ca++ channels, and diazepam suppressed an increase in intracellular Ca++ evoked by 80 mM extracellular K+ as measured by the fura-2 method. These results suggest that the inhibitory action of diazepam and other benzodiazepines on DA release from PC12 cells may be mediated through one type of peripheral-type benzodiazepine receptors which are coupled to voltage-gated Ca++ channels and that these receptors may not necessarily be the same as those in other tissues.

Original languageEnglish
Pages (from-to)484-489
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume259
Issue number2
Publication statusPublished - Dec 1 1991
Externally publishedYes

Fingerprint

PC12 Cells
Pheochromocytoma
Benzodiazepines
Diazepam
Dopamine
GABA-A Receptors
Clonazepam
Flumazenil
Fura-2
Inhibitory Concentration 50

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Cite this

Inhibitory action of peripheral-type benzodiazepines on dopamine release from PC12 pheochromocytoma cells. / Ohara-Imaizumi, M.; Nakazawa, K.; Obama, T.; Fujimori, K.; Takanaka, A.; Inoue, K.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 259, No. 2, 01.12.1991, p. 484-489.

Research output: Contribution to journalArticle

Ohara-Imaizumi, M. ; Nakazawa, K. ; Obama, T. ; Fujimori, K. ; Takanaka, A. ; Inoue, K. / Inhibitory action of peripheral-type benzodiazepines on dopamine release from PC12 pheochromocytoma cells. In: Journal of Pharmacology and Experimental Therapeutics. 1991 ; Vol. 259, No. 2. pp. 484-489.
@article{bea4ddc7ba584d5d93725c89cf84d2d5,
title = "Inhibitory action of peripheral-type benzodiazepines on dopamine release from PC12 pheochromocytoma cells",
abstract = "Characteristics of the benzodiazepine inhibition of dopamine (DA) release in PC12 cells were investigated. Diazepam inhibited DA release evoked by high concentrations of extracellular. K+ in a dose-dependent manner (IC50, 10 μM). Ro 5-4864 [7-chloro-1,3-dihydro-1-methyl-5-(p-chlorophenyl)-2H-1,4- benzodiazepine-2-one], a peripheral-type benzodiazepine, also inhibited DA release effectively. PK 11195 [1-(2-chlorophenyl)-N-methyl-N-(1- methylpropyl)-3-isoquinoline carboxamide], a benzodiazepine generally considered a peripheral-type benzodiazepine receptor antagonist, did not antagonize the inhibition induced by diazepam, but rather inhibited DA release itself. On the other hand, the central-type benzodiazepines, clonazepam and Ro 15-1788 {ethyl-8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H- imidazo[1,5a][1,4]benzodiazepine-3-carboxylate} did not affect the DA release. Diazepam, Ro 5-4864 and PK 11195 also inhibited a Ba++-current carried by voltage-gated Ca++ channels, and diazepam suppressed an increase in intracellular Ca++ evoked by 80 mM extracellular K+ as measured by the fura-2 method. These results suggest that the inhibitory action of diazepam and other benzodiazepines on DA release from PC12 cells may be mediated through one type of peripheral-type benzodiazepine receptors which are coupled to voltage-gated Ca++ channels and that these receptors may not necessarily be the same as those in other tissues.",
author = "M. Ohara-Imaizumi and K. Nakazawa and T. Obama and K. Fujimori and A. Takanaka and K. Inoue",
year = "1991",
month = "12",
day = "1",
language = "English",
volume = "259",
pages = "484--489",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Inhibitory action of peripheral-type benzodiazepines on dopamine release from PC12 pheochromocytoma cells

AU - Ohara-Imaizumi, M.

AU - Nakazawa, K.

AU - Obama, T.

AU - Fujimori, K.

AU - Takanaka, A.

AU - Inoue, K.

PY - 1991/12/1

Y1 - 1991/12/1

N2 - Characteristics of the benzodiazepine inhibition of dopamine (DA) release in PC12 cells were investigated. Diazepam inhibited DA release evoked by high concentrations of extracellular. K+ in a dose-dependent manner (IC50, 10 μM). Ro 5-4864 [7-chloro-1,3-dihydro-1-methyl-5-(p-chlorophenyl)-2H-1,4- benzodiazepine-2-one], a peripheral-type benzodiazepine, also inhibited DA release effectively. PK 11195 [1-(2-chlorophenyl)-N-methyl-N-(1- methylpropyl)-3-isoquinoline carboxamide], a benzodiazepine generally considered a peripheral-type benzodiazepine receptor antagonist, did not antagonize the inhibition induced by diazepam, but rather inhibited DA release itself. On the other hand, the central-type benzodiazepines, clonazepam and Ro 15-1788 {ethyl-8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H- imidazo[1,5a][1,4]benzodiazepine-3-carboxylate} did not affect the DA release. Diazepam, Ro 5-4864 and PK 11195 also inhibited a Ba++-current carried by voltage-gated Ca++ channels, and diazepam suppressed an increase in intracellular Ca++ evoked by 80 mM extracellular K+ as measured by the fura-2 method. These results suggest that the inhibitory action of diazepam and other benzodiazepines on DA release from PC12 cells may be mediated through one type of peripheral-type benzodiazepine receptors which are coupled to voltage-gated Ca++ channels and that these receptors may not necessarily be the same as those in other tissues.

AB - Characteristics of the benzodiazepine inhibition of dopamine (DA) release in PC12 cells were investigated. Diazepam inhibited DA release evoked by high concentrations of extracellular. K+ in a dose-dependent manner (IC50, 10 μM). Ro 5-4864 [7-chloro-1,3-dihydro-1-methyl-5-(p-chlorophenyl)-2H-1,4- benzodiazepine-2-one], a peripheral-type benzodiazepine, also inhibited DA release effectively. PK 11195 [1-(2-chlorophenyl)-N-methyl-N-(1- methylpropyl)-3-isoquinoline carboxamide], a benzodiazepine generally considered a peripheral-type benzodiazepine receptor antagonist, did not antagonize the inhibition induced by diazepam, but rather inhibited DA release itself. On the other hand, the central-type benzodiazepines, clonazepam and Ro 15-1788 {ethyl-8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H- imidazo[1,5a][1,4]benzodiazepine-3-carboxylate} did not affect the DA release. Diazepam, Ro 5-4864 and PK 11195 also inhibited a Ba++-current carried by voltage-gated Ca++ channels, and diazepam suppressed an increase in intracellular Ca++ evoked by 80 mM extracellular K+ as measured by the fura-2 method. These results suggest that the inhibitory action of diazepam and other benzodiazepines on DA release from PC12 cells may be mediated through one type of peripheral-type benzodiazepine receptors which are coupled to voltage-gated Ca++ channels and that these receptors may not necessarily be the same as those in other tissues.

UR - http://www.scopus.com/inward/record.url?scp=0026342086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026342086&partnerID=8YFLogxK

M3 - Article

C2 - 1658299

AN - SCOPUS:0026342086

VL - 259

SP - 484

EP - 489

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -